insulin epitope peptide B15-23

What is insulin epitope peptide B15-23

**Introduction to Insulin Epitope Peptide B15-23** Insulin epitope peptide B15-23 (sequence: HLVEALYLVC) is a well-studied immunogenic fragment derived from the B-chain of insulin. This 9-amino acid peptide plays a key role in autoimmune diabetes research, particularly in the context of type 1 diabetes (T1D), where it is recognized by cytotoxic T cells targeting pancreatic β-cells. As a major histocompatibility complex (MHC) class I-restricted epitope, B15-23 is instrumental in studying T-cell-mediated immune responses and developing therapeutic strategies, such as antigen-specific immunomodulation. Its high binding affinity to the H-2Kᵈ MHC molecule in mice makes it a valuable tool for preclinical studies in diabetes models, aiding the exploration of tolerance induction and autoimmune mechanisms.

Preparation Process: The insulin epitope peptide B15-23 (HLVEALYLVC) can be prepared via solid-phase peptide synthesis (SPPS) using Fmoc chemistry. Begin by attaching Fmoc-Cys(Trt)-OH to a Rink amide resin. Sequentially couple Fmoc-protected amino acids (Fmoc-Val-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Leu-OH, Fmoc-Ala-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Val-OH, Fmoc-Leu-OH, Fmoc-His(Trt)-OH) using HBTU/HOBt/DIPEA activation. After each coupling, deprotect with 20% piperidine/DMF. Cleave the peptide from the resin with TFA/TIS/water (95:2.5:2.5) for 2 hours, then precipitate in cold ether. Purify via reverse-phase HPLC (C18 column, acetonitrile/water gradient) and confirm by mass spectrometry. Lyophilize the pure peptide for storage.

Usage Scenarios: The compound insulin epitope peptide B15-23 is primarily used in immunological research to study T-cell responses, particularly in the context of type 1 diabetes (T1D). It serves as a key antigenic target for autoreactive CD8+ T cells, helping researchers investigate autoimmune mechanisms. This peptide is employed in ELISPOT assays, tetramer staining, and T-cell proliferation studies to assess immune reactivity. Additionally, it aids in evaluating potential immunotherapies and vaccines aimed at modulating T-cell activity in T1D. Its role in HLA-A*02:01-restricted immune responses makes it valuable for understanding beta-cell destruction and developing diagnostic tools for autoimmune diabetes.

insulin epitope peptide B15-23 Basic Info

insulin epitope peptide B15-23 Price